about
PodocytesPodometrics as a Potential Clinical Tool for Glomerular Disease ManagementThe directed differentiation of human iPS cells into kidney podocytesQuantitative and qualitative urinary cellular patterns correlate with progression of murine glomerulonephritisConditionally immortalized human podocyte cell lines established from urine.Urinary podocyte-associated mRNA profile in various stages of diabetic nephropathy.A systems view of genetics in chronic kidney diseasePodocyte injury damages other podocytes.Persistent urinary podocyte loss following preeclampsia may reflect subclinical renal injuryPodocyturia: Is there any clinical utility?Direct evidence of podocyte damage in cardiorenal syndrome type 2: preliminary evidence.The two kidney to one kidney transition and transplant glomerulopathy: a podocyte perspectiveValproic acid attenuates proteinuria and kidney injury.Urine podocyte mRNAs mark disease activity in IgA nephropathy.Macrophages mediate lung inflammation in a mouse model of ischemic acute kidney injury.Strategy and rationale for urine collection protocols employed in the NEPTUNE study.Genomic biomarkers for chronic kidney disease.Podocyte Depletion in Thin GBM and Alport Syndrome.Growth-dependent podocyte failure causes glomerulosclerosis.Urine podocin:nephrin mRNA ratio (PNR) as a podocyte stress biomarkerRecent progress in the pathophysiology and treatment of FSGS recurrence.HDAC inhibitors in experimental liver and kidney fibrosis.Alteration of podocyte phenotype in the urine of women with preeclampsiaMembranous expression of podocalyxin-like protein is an independent factor of poor prognosis in urothelial bladder cancer.Angiotensin II-dependent persistent podocyte loss from destabilized glomeruli causes progression of end stage kidney diseaseUrinary nephrin: A new predictive marker for pregnancies with preeclampsia and small-for-gestational age infants.Defining cell-type specificity at the transcriptional level in human diseaseDistinct metabolic profile of primary focal segmental glomerulosclerosis revealed by NMR-based metabolomics.Urine podocyte mRNAs, proteinuria, and progression in human glomerular diseases.A compendium of urinary biomarkers indicative of glomerular podocytopathy.Urinary exosomal Wilms' tumor-1 as a potential biomarker for podocyte injury.New insights into the renoprotective actions of the renin inhibitor aliskiren in experimental renal disease.Pathogenesis and therapy of focal segmental glomerulosclerosis: an update.Relationship between urinary podocytes and kidney diseases.Dipping your feet in the water: podocytes in urine.Renin-angiotensin system within the diabetic podocyte.Human Urine as a Noninvasive Source of Kidney Cells.Growth Hormone Induces Transforming Growth Factor-Beta-Induced Protein in Podocytes: Implications for Podocyte Depletion and Proteinuria.Targeting mTOR Signaling Can Prevent the Progression of FSGS.Podocytes from the diagnostic and therapeutic point of view.
P2860
Q26766118-8DE13991-C39B-46E2-8923-E51FE5347D12Q26799182-780DAEF8-99DD-4FDE-AE93-954312A64AAFQ27316230-E798C900-B0E1-4076-A2F7-15926D184B84Q30999305-DE0E42BE-A329-4C69-BD64-FE1B406E4DD8Q33727877-12BDD4A3-707E-4BC9-A695-B3CA429F58F0Q33926992-C7F7559F-3766-4E60-8C5F-FC3A2CC69463Q34475363-63E97AB5-F547-4922-9C44-2DF29971B0A9Q35108875-1C0E2316-0634-439A-9FA6-64212916AC20Q35130326-3B39161F-B39B-476D-8BCA-0769AA243B59Q35351182-C49D63C9-8F7D-4E9E-8B15-8B5F29147DAFQ35592469-BAA3E993-92C9-4831-9279-3476F59541EBQ35658590-70098A50-6129-4568-8160-ABD59A240471Q35758297-71C4DB44-73D4-44B3-85D5-2DABE2E3E42EQ35777614-FBAFD041-A74B-43D0-B278-59D7E8810425Q35787428-D936B6FC-6F2D-4211-B893-DDA00A3E05A2Q35844134-6743AA23-D630-4B4F-B87F-2B6A94E57AFFQ35896442-0401A574-9A0A-47B6-8FB0-8AA0B9702BC4Q36021415-2DCC61B4-7F8E-452D-994D-FDDF9418609EQ36109205-5E8EA033-9B18-45F2-9F3C-6DC38D45C6C5Q36389219-01CFDED4-831A-46DD-9015-D3AAE8026E89Q36572659-40A91D25-85D4-486C-9629-C672A3FBD391Q36588493-518D70E5-E95D-4360-A277-FEBED2A17FB8Q36773959-3EFBF7F7-7B95-47D6-A943-EC6463CE2BF3Q36924797-463047ED-B4B7-486A-8FC4-3A6E3D1118E1Q37085058-6CC1B5EC-811B-4F77-9CD2-290F37CE5523Q37199931-6B6836D6-B18A-4CE8-8F51-38C155081A7DQ37272437-4334D7F2-4223-457B-84E6-29A049CFEDB3Q37297472-4E58E176-C862-4BA0-BF92-DCB81FD43783Q37340215-445C1849-1437-4BB8-BC5B-94B08B875567Q37353481-CB4809B2-7A8C-4453-BAEA-903B006B94E5Q37476603-0490991D-52E3-43CB-AAA6-FA94E29CE102Q37702782-48DCB722-54EF-4648-B740-710842B0B8ECQ37812564-F1739BC2-EBC4-4163-9BF8-A6BD26EE0597Q37976448-3883305A-C099-4F6B-ADDE-72C8344E9604Q38203904-456EB8D8-296D-447F-B459-F080F1E05E02Q38262105-5E6596BB-343E-4126-A50E-8CDBE86931A9Q38531972-23D18170-8128-4B9B-A982-6E252E57BD76Q38903408-C9CF79E3-A96B-43B4-9CC9-4B3F05924ECFQ38922365-C584643A-7DB4-4447-92FA-4285E489A513Q39309473-B41A85EC-0C23-4979-B81B-58C7A04286A3
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 23 April 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Urine podocyte mRNAs mark progression of renal disease.
@en
Urine podocyte mRNAs mark progression of renal disease.
@nl
type
label
Urine podocyte mRNAs mark progression of renal disease.
@en
Urine podocyte mRNAs mark progression of renal disease.
@nl
prefLabel
Urine podocyte mRNAs mark progression of renal disease.
@en
Urine podocyte mRNAs mark progression of renal disease.
@nl
P2093
P2860
P356
P1476
Urine podocyte mRNAs mark progression of renal disease.
@en
P2093
Bryan L Wharram
Chrysta Lienczewski
Jai Won Chang
Jocelyn E Wiggins
Larysa Wickman
Madhusudan Venkatareddy
Matthias Kretzler
Meera Goyal
Sang Koo Lee
P2860
P304
P356
10.1681/ASN.2007121328
P577
2009-04-23T00:00:00Z